Part of the HDFCCC K12 Concept to Completion, Strategies for Successful Clinical Trials. Learning objectives for this seminar are:

• Describe the difference between objectives vs endpoints
• Identify basic biostatistical methods in therapeutic and nontherapeutic clinical oncology trials  
• Explain different types of innovative clinical trial design (e.g., phase 0, biomarker-driven, and adaptive designs)
• Discuss tips of the trade- accommodating a limited budget/sample size, the role of an interim analysis (futility, safety, efficacy), use of safety lead-ins
• Summarize tips for reviewing clinical data and pitfalls to avoid 

Speakers:

• Pamela Munster, MD, Professor, Department of Medicine (Hematology/Oncology), UCSF; Director, Early Phase Clinical Trials Unit, Co-leader of the Center for BRCA Research, and Co-Leader, Molecular Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center
• Ann Lazar, PhD, MS, Professor, Preventative and Restorative Dental Science, UCSF School of Dentistry 

Register here.